Belinda Lee

Oncologist & Head of Cancer Clinical Trials Unit

Australia

Research Interests

Explore related searches

Professors in Australia Professors in Medical Imaging Medical Imaging professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Belinda Lee is an Oncologist and Head of the Cancer Clinical Trials Unit at Northern Health, Australia. Her research focuses on cancer treatment outcomes, particularly in pancreatic and colorectal cancers, as demonstrated by her recent articles exploring multidisciplinary team meetings, real-world outcomes of EGFR inhibitor use, and the impact of cultural and linguistic diversity on treatment. Dr. Lee is committed to addressing health disparities and improving patient care through innovative research and clinical practices.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (9)

Sharon Pattison

Associate Professor Molecular Medical Oncology

University of Auckland

NEW ZEALAND

View details

Neil Strugnell

Head of Colorectal Surgery Unit

Northwell Health

AUSTRALIA

View details

Nadia Kershaw

Laboratory Head

Walter and Eliza Hall Institute of Medical Research

AUSTRALIA

View details

Timothy J. Price

AUSTRALIA

View details

Laura Dagley

Walter and Eliza Hall Institute of Medical Research

AUSTRALIA

View details

Fiona Day

Conjoint Associate Professor

Newcastle University

AUSTRALIA

View details

Michael Griffin

University of Melbourne

AUSTRALIA

View details

Nirupa Sachithanandan

University of Melbourne

AUSTRALIA

View details

Desmond Yip

Professor (Full)

Australian National University Medical School

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Belinda Lee

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Neoadjuvant Chemotherapy With Chemoradiotherapy for Patients With Borderline Resectable or Locally Advanced Pancreatic Ductal Adenocarcinoma—Retrospective Review From a Tertiary Care Hospital

A Scoping Review on the Data Utility, Clinical Impact, and Cost of Multidisciplinary Team Meetings for Pancreatic Cancer

Exploring Real-World Outcomes of First Line EGFR Inhibitor Use, Cetuximab Versus Panitumumab, in Patients with Left-Sided, RAS Wild-Type, Metastatic Colorectal Cancer

Exploring the association between Cultural and Linguistic Diversity (CALD) on treatment and outcomes in pancreatic cancer: an analysis of PURPLE real-world registry data from an Australian population

Initial Assessment of Resectability of Colorectal Cancer Liver Metastases Versus Clinical Outcome

Measuring quality in the care of metastatic colorectal cancer utilising available registry data: A modified Delphi study

Real-world impact of pembrolizumab availability for deficient mismatch repair metastatic colorectal cancer

Skeletal muscle and visceral fat density are predictive imaging biomarkers for overall survival in patients with pancreatic adenocarcinoma: A retrospective multicenter analysis

Early onset pancreatic cancer—exploring contemporary treatment and outcomes using real-world data

Evolution of Liquid Biopsies for Detecting Pancreatic Cancer

Addressing disparities in health outcomes for patients with advanced pancreatic cancer and limited English proficiency

Correction to: S100 family proteins are linked to organoid morphology and EMT in pancreatic cancer

S100 family proteins are linked to organoid morphology and EMT in pancreatic cancer

ASCEND: a randomised, double-blinded, placebo-controlled, phase II study of gemcitabine and nab-paclitaxel with LSTA1 in untreated metastatic pancreatic adenocarcinoma. An Australasian Gastro-Intestinal Trials Group (AGITG) trial

Compliance with Therapeutic Goods Association prescribing information: weekly or second weekly cetuximab for the treatment of metastatic colorectal cancer

An integrated interpreting service normalizes access to care for culturally and linguistically diverse (CALD) patients with colorectal cancer

Changing patterns of care for pancreas cancer in Victoria: the 2022 <scp>Pancreas Tumour Summit</scp>

Current state of radiomic research in pancreatic cancer: focusing on study design and reproducibility of findings

Imaging for assessment of cancer treatment response to immune checkpoint inhibitors can be complementary in identifying hypophysitis

Use and outcomes from neoadjuvant chemotherapy in borderline resectable pancreatic ductal adenocarcinoma in an Australasian population.

Collaborators (9)

Sharon Pattison

Neil Strugnell

Nadia Kershaw

Timothy J. Price

Laura Dagley

Fiona Day

Michael Griffin

Nirupa Sachithanandan

Desmond Yip

Make your next move.